News
-
Gonadotrophin a-flag
Thursday | Aug 3 2017THE Pharmaceutical Benefits Scheme (PBS) advises pharmacists that an a-flag should have been applied to the following items in the Aug data, the item codes for these human chorionic gonadotrophin products considered equivalent for the purposes of substitution: 11148R and 1581F; 11154C and 6178E; 11156E and 6181H.
-
PSA staffer takes off
Thursday | Aug 3 2017NEWLY formed aviation lobby group Airlines for Australia and New Zealand (A4ANZ) has today announced the appointment of the Pharmaceutical Society of Australia's (PSA's) Dr Alison Roberts (pictured) as its inaugural ceo.
-
PBS website update
Thursday | Aug 3 2017THE latest update to the Pharmaceutical Benefits Scheme (PBS) website includes advance notice for Sep changes to the prescriber bag, the usual additions, deletions and alterations pages, as well as highly specialised drugs program adjustments, IVF program updates, chemotherapy funding and more.
-
Guild supports carers
Thursday | Aug 3 2017THE Pharmacy Guild has announced its sponsorship for the upcoming 7th International Carers Conference which will take place at the Adelaide Convention Centre from 04-06 Oct this year.
-
RB settles for $3.5m
Thursday | Aug 3 2017NUROFEN manufacturer Reckitt Benckiser (RB) will pay $3.5m compensation to consumers who, according to their class action, claim to have been misled by the company's Specific Pain range packaging.
-
NZ group strong
Thursday | Aug 3 2017NEW Zealand listed pharmacy group Green Cross Health says it's not concerned about plans by Chemist Warehouse to launch across the Tasman (PD 18 Jul).
-
Gorilla missed TGA
Thursday | Aug 3 2017THE TGA has warned that 'Germany Black Gorilla' tablets pose a serious risk to health and should not be taken, containing the undeclared prescription-only substance sildenafil.
-
FDA ticks Imbruvica
Thursday | Aug 3 2017THE US Food and Drug Administration (FDA) has expanded the approval of Imbruvica (ibrutinib) to include the treatment of adult patients with chronic graft versus host disease (cGVHD) under specific conditions, the first FDA-approved therapy for cGVHD.
-
NPSA joins anti-Review chorus
Thursday | Aug 3 2017THE National Pharmaceutical Services Association (NPSA) has called for a more robust assessment of the role Australia's full-line wholesalers play in the delivery of the National Medicines Policy (NMP) in its response to the Review of Pharmacy Regulation and Remuneration's Interim Report.
-
API warns of soft demand
Thursday | Aug 3 2017AUSTRALIAN Pharmaceutical Industries yesterday halved its profit growth expectations, saying it now expects its results for the 12 months to 31 Aug to be up 5% on the previous financial year (PD breaking news yesterday).
